Novartis to acquire UK-based ocular gene therapy company

Swiss pharmaceutical giant Novartis said Wednesday it was to acquire a UK-based biotech company developing gene therapies for eye diseases called Gyroscope Therapeutics.

This article was originally published on this website.

Popular Articles: